Making The Case For Case Management For Cell And Gene Therapies

Cell and gene therapies hold the potential to treat a number of serious or even life-threatening diseases with previously unmet medical needs. However, as demand for more advanced therapies increases in the market, so does the need for more specialized supply chain support for these types of products, which have very strict transportation and handling requirements.

Deviations from the intended supply chain can delay timelines and affect the products themselves, which can be detrimental to budgets as these are high value products, but more importantly can have dire effects on the patients whose lives depend on receiving these critical doses safely and on time.

It is crucial to ensure that supply chain risks are mitigated, as well as have proactive strategies in place to address unforeseen challenges before they become an issue. A dedicated Case Manager provides end-to-end supply chain management and 24/7 oversight and support to help ensure the seamless manufacturing and distribution of each cell or gene therapy dose to every patient.